Market Overview:
The global Abilify Maintena market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of mental disorders, increasing demand for long-acting injectable drugs, and growing awareness about mental health. The global Abilify Maintena market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into 300mg and 400mg. On the basis of application, the market is segmented into hospital, clinic, and drug store. The North America region dominates the global Abilify Maintena market followed by Europe and Asia Pacific regions respectively.
Product Definition:
Aripiprazole extended-release injectable suspension (Abilify Maintena) is an atypical antipsychotic agent indicated for the maintenance treatment of schizophrenia.
300mg:
300mg, it’s usage.
300 mg is a standard dose for schizophrenia. It has been observed that the average daily dose of antipsychotic medication for patients diagnosed with schizophrenia is around 6 to 8 mg. However, there are some cases where the dosage may go up to as high as 15 to 20 mg per day.
400mg:
400mg is used for the treatment of schizophrenia. It works by improving the activity of certain chemicals (neurotransmitters) in the brain. More than one type of medicine may be used along with this to improve effectiveness and reduce side effects. 400 mg is usually divided into two doses; 100 mg given once a day, and 200 mg twice a day The medicine has been studied to help people who have recently stopped taking their regular dose of antipsychotic medication or are experiencing relapse.
Application Insights:
The market is segmented by application into hospital, clinic and drugstore. The hospital held the largest share of the global Abilify Maintena market in 2017 owing to increasing prevalence of mental disorders globally coupled with a rise in demand for acute treatment is driving this segment. Increasing number of hospitals and clinics has also facilitated easy access to medication for patients which may require emergency care along with better monitoring facilities leading to an increase in revenue generation opportunities for manufacturers.
Clinic application was estimated as the second-largest segment due to rising awareness about mental health conditions and growing pressure on doctors from patients seeking their advice regarding symptoms such as anxiety, irritability or insomnia at any point of time during day or night. This trend has led manufacturers like Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis AG et al.
Regional Analysis:
North America was the largest market in 2017 and accounted for a revenue share of around 41.0%. The region will retain its leading position throughout the forecast years on account of increasing cases of obesity and diabetes in U.S., which is expected to boost Abilify Maintena demand. In addition, favorable reimbursement policies for commercial payers are further expected to support growth over the next eight years.
Asia Pacific is anticipated to be one of the fastest-growing regions with a CAGR exceeding 6% from 2018 to 2030 owing to rising healthcare expenditure, improving economic conditions, expanding patient base across rural as well as urban areas along with growing awareness about new treatment options offered by manufacturers.
Growth Factors:
- Increasing incidence of mental disorders: The increasing incidence of mental disorders is one of the key growth drivers for the Abilify Maintena market. According to a study by the World Health Organization (WHO), around 450 million people suffer from some form of mental disorder, which is equivalent to 6.3% of the global population. This number is expected to increase in the coming years due to various factors such as changing lifestyles, stress, and pollution. This will create a high demand for drugs such as Abilify Maintena that can help in treating these disorders effectively.
- Rising awareness about mental health: There has been a significant rise in awareness about mental health in recent years among both patients and healthcare professionals alike. This has led to an increased demand for treatments for various psychiatric conditions, which is benefiting players operating in this market space such as Otsuka Pharmaceuticals Co., Ltd., Bristol-Myers Squibb Company, and others..
- Technological advancements: The field of psychiatry has witnessed several technological advancements over the past few years with respect to diagnosis and treatment options available for patients suffering from various psychiatric conditions .This is benefiting players operating in this market space by providing them with opportunities to introduce novel products that can address unmet needs prevailing among patients .For instance ,Otsuka Pharmaceuticals Co., Ltd recently launched its long-acting injectable formulation called ABILIFY MAINTENA (aripiprazole) injection 400
Scope Of The Report
Report Attributes
Report Details
Report Title
Abilify Maintena Market Research Report
By Type
300mg, 400mg
By Application
Hospital, Clinic, Drugs Store
By Companies
Otsuka, Lundbeck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Abilify Maintena Market Report Segments:
The global Abilify Maintena market is segmented on the basis of:
Types
300mg, 400mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Drugs Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Otsuka
- Lundbeck
Highlights of The Abilify Maintena Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 300mg
- 400mg
- By Application:
- Hospital
- Clinic
- Drugs Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Abilify Maintena Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Abilify Maintena is a medication used to treat schizophrenia and bipolar disorder. It works by changing the way the brain processes information. Abilify Maintena is usually taken once daily.
Some of the major companies in the abilify maintena market are Otsuka, Lundbeck.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Abilify Maintena Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Abilify Maintena Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Abilify Maintena Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Abilify Maintena Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Abilify Maintena Market Size & Forecast, 2020-2028
4.5.1 Abilify Maintena Market Size and Y-o-Y Growth
4.5.2 Abilify Maintena Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 300mg
5.2.2 400mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Drugs Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Abilify Maintena Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Abilify Maintena Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 300mg
9.6.2 400mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Drugs Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 300mg
10.6.2 400mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Drugs Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 300mg
11.6.2 400mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Drugs Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 300mg
12.6.2 400mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Drugs Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 300mg
13.6.2 400mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Drugs Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Abilify Maintena Market: Competitive Dashboard
14.2 Global Abilify Maintena Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Otsuka
14.3.2 Lundbeck
